If you enjoy this content, please share it with a colleague
Philips
RELATED CONTENT
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland), the site started applying the acceleration possibilities for their MRI scans of the brain, spine and joints, as well as pelvis and abdomen. Using Compressed SENSE appeared a simple yet powerful way to accelerate MRI scanning for different contrast types and sequences, in 2-D as well as 3-D. The significantly reduced scan times convinced the team to plan for adjusting all their ExamCards, with the objective to shorten patient timeslots and then actually plan for increasing their number of MRI patients per day. This is of strategic importance to help them generate revenue when reimbursements go down.
Nuclear imaging technology for both single photon emission computed tomography (SPECT) and positron emission tomography (PET) have made advancements in the past couple years. The main drivers for this have been a movement to digital imaging detectors to improve image quality and address radiation dose concerns, reimbursement and radiotracer supply issues. Other advancements have come in the areas of software to improve image reconstruction quality, offer better clinical qualification and analytics data.
Philips recently announced the introduction of the Epiq CVx cardiovascular ultrasound system. Built on the Epiq ultrasound platform, Epiq CVx is specifically designed to increase diagnostic confidence and simplify workflow for clinicians, giving them more time to interact with their patients and reducing the need for repeat scans. According to Philips, 95 percent of a group of clinicians who were shown the new system believed it offered improved image quality: sharper and clearer images [1]. Philips is also introducing the Epiq CVxi, specifically tailored for use in the interventional lab. Both systems are CE marked and have received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Intel and Philips recently tested two healthcare uses for deep learning inference models using Intel Xeon Scalable processors and the OpenVINO toolkit. One use case focused on X-rays of bones for bone-age-prediction modeling, the other on computed tomography (CT) scans of lungs for lung segmentation. In these tests, Intel and Philips achieved a speed improvement of 188 times for the bone-age-prediction model, and a 38 times speed improvement for the lung-segmentation model over the baseline measurements.
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging industry, announced the category winners of the 2017-18 IMV ServiceTrak in PET Imaging. Philips North America was the winner in the Best Service category, while GE Healthcare came out on top in Best Customer Satisfaction.
Philips announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Ingenia Elition 3.0T magnetic resonance imaging (MRI) solution and two clinical applications, Philips Compressed Sense and 3D APT. This integrated suite of innovations enables clinicians to perform exams up to 50 percent faster [1], increase diagnostic confidence and improve the patient experience.
The power to predict a cardiac arrest, support a clinical diagnosis or nudge a provider when it is time to issue ...
Many say it is very difficult or impossible to go through the large volumes of data to pick out what is clinically ...
As healthcare systems continue to expand through consolidation and the amount of data generated by patients grows ...
Philips Healthcare last week issued a proactive advisory warning to its iSite and IntelliSpace picture archiving and communication system (PACS) customers of potential security vulnerabilities in the products. The company cautioned that while it has received no reports of patient harm, the vulnerabilities in question could impact or potentially compromise patient confidentiality, system integrity and/or system availability.